Open Access Open Access  Restricted Access Subscription or Fee Access

In Silico Identification of Genes, Coding Sequences for Iron Source and Drug Targets from Haemophilus Ducreyi

R. Padmapriya, Puniethaa Prabhu


Haemophilus ducreyi strain 35000HD is responsible for causing chancroid, one of the most common sexually transmitted disease prevailing globally. Although extensive researches are in progress in order to control the transmission of the disease and to develop drugs against the pathogen, till date no effective vaccine or specific drug are developed and only antibiotic treatment is in use. Due to excess use of antibiotics, several resistant strains such as Herpes simplex, chlamydia trachomatis virus have been found. In the present study, candidate drug and vaccine targets are identified from Haemophilus ducreyi virulent strain 35000HD using in silico subtractive genomics approach. Essential genes are responsible for virulence nature and support the growth of microorganism. 531 essential genes of Haemophilus ducreyi are expressed beneath in vivo. Out of 531 essential genes, 125 genes are identified as essential, 12 are iron source coding genes. These essential enzymes are found to be the potential drug targets from the host pathogen. From the identified proteins, Ferritin and transferrin are expected to be better possible drug targets. Screening of the functional inhibitors against these drug targets may result in discovery of novel therapeutic drugs that can be effective for the antibiotic resistant strains.


Haemophilus Ducreyi, Essential Genes, Genes Coding Iron Source, Candidate Vaccine Targets.

Full Text:



Michelle Alfa., “The laboratory diagnosis of Haemophilus ducreyi”. Infect Dis Med Microbiol vol.16, 2005, pp. 31-34.

E.Margaret, Bauer, A. Carisa, R Townsend, Ryan , R.Doster, Kate, W. Fortney, Beth , Zwickl, P. Barry, Katz, M. Stanley . Spinola and M. Diane M. Janowicz., “A Fibrinogen-Binding Lipoprotein Contributes to the Virulence of Haemophilus ducreyi in Humans”. The Journal of Infectious Diseases, vol 199, 2009, pp. 684 –92.

G.Koteswara Reddy, K. Nagamalleswara Rao , B. Phani Rama Krishna and Aravind, “In silico identification of potential therapeutic targets in Clostridium botulinumby the approach subtractive genomics,” International Journal of Bioinformatics Research, vol. 2, no. 2, 2010, pp. 12-16.

Deepak Perumal, Chu Sing Lim, R.Kishore, Sakharkar and K.Meena , “Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification,” In silico biology, vol. 7 , 2007, pp. 453-65.

M. G. Mcentegart, S. Hafiz and G. R. Kinghorn J. Hyg., Camb., “Haemophilus ducreyi infections - time for reappraisal” vol. 89, 1982, pp. 467-478.

W. Jacqueline, Chung, Mario Jacques and W. James Coulton, “Outer Membrane Proteins and Iron Uptake of Actinobacillus pleuropneumoniae,” Journal of Molecular Graphics and Modelling, vol. 23, 2004, pp 211–221.

R.Zhang, Ou HY, et al, “DEG:A Database of Essential Genes nucleic acids”( vol. 32,2004. Pp.271-D272.

Debmalyabarh and Amerendra Narayanamisra, “in silico identification of membrane associated drug targets in Neisseria gonorrhoeae,” Intermational journal of integrative biology , vol. 6, 2009, pp.265.

Maria Labandeira- Rey, A Chad , Brautigam, and J Eric . Hansen. “Characterization of the CpxRA Region in Haemophilus ducreyi”. Infection and immunity, vol. 78, 2010, pp. 4779–4791.

JL Gardy., “PSORTb V.2.0: Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis,” Bioinformatics vol. 72 , 2005, pp. 6757-6763.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.